Advancing "Organ-on-a-Chip" Technology for Pre-Clinical AAV Safety Testing within the Adeno-associated Virus Vector-based Gene Therapy Sector for Late 2025
The way AAV therapies are tested before they reach human trials is undergoing a radical transformation in late 2025. "Organ-on-a-chip" technology—which uses human cells to recreate the function of a liver, heart, or brain on a microchip—is increasingly being used to predict how a viral vector will behave in a person. This is far more accurate than traditional animal models, as AAV...
0 Comments 0 Shares 323 Views 0 Reviews
Sponsored

Earn Money by Sharing! Simple • Fast • 100% Legit

Start making money online with just a single link. Share the link on WhatsApp, Instagram, Facebook, or anywhere — every click turns into real earnings. No investment, no skills required. Fast...